NCT06130410View on ClinicalTrials.gov

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

CompletedOBSERVATIONAL

Enrollment

25

Participants

Timeline

Start Date

March 6, 2024

Primary Completion Date

July 26, 2024

Study Completion Date

July 26, 2024

Conditions

SARS-CoV-2COVID-19

Interventions

BIOLOGICAL

COMIRNATY intramuscular injection

Booster injection in the muscle, 1 dose

Trial Locations (1)

1518589

Pfizer Local Country, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY